Your browser doesn't support javascript.
loading
Therapeutic Implications of p53 Status on Cancer Cell Fate Following Exposure to Ionizing Radiation and the DNA-PK Inhibitor M3814.
Sun, Qing; Guo, Yige; Liu, Xiaohong; Czauderna, Frank; Carr, Michael I; Zenke, Frank T; Blaukat, Andree; Vassilev, Lyubomir T.
Afiliação
  • Sun Q; Translational Innovation Platform Oncology, EMD Serono Research and Development Institute, Inc., Billerica, Massachusetts.
  • Guo Y; Translational Innovation Platform Oncology, EMD Serono Research and Development Institute, Inc., Billerica, Massachusetts.
  • Liu X; Translational Innovation Platform Oncology, EMD Serono Research and Development Institute, Inc., Billerica, Massachusetts.
  • Czauderna F; Translational Innovation Platform Oncology, EMD Serono Research and Development Institute, Inc., Billerica, Massachusetts.
  • Carr MI; Translational Innovation Platform Oncology, EMD Serono Research and Development Institute, Inc., Billerica, Massachusetts.
  • Zenke FT; Translational Innovation Platform Oncology, Biopharma Research and Development, Merck KGaA, Darmstadt, Germany.
  • Blaukat A; Translational Innovation Platform Oncology, Biopharma Research and Development, Merck KGaA, Darmstadt, Germany.
  • Vassilev LT; Translational Innovation Platform Oncology, EMD Serono Research and Development Institute, Inc., Billerica, Massachusetts. lubo.vassilev@emdserono.com.
Mol Cancer Res ; 17(12): 2457-2468, 2019 12.
Article em En | MEDLINE | ID: mdl-31551253

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Biomarcadores Tumorais / Neoplasias do Colo do Útero / Proteína Supressora de Tumor p53 / Neoplasias Pulmonares Limite: Female / Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Biomarcadores Tumorais / Neoplasias do Colo do Útero / Proteína Supressora de Tumor p53 / Neoplasias Pulmonares Limite: Female / Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article